Publications en collaboration avec des chercheurs de University of Chicago Medical Center (10)

2022

  1. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

    Nature Medicine, Vol. 28, Núm. 2, pp. 325-332

2020

  1. First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma

    Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317

2019

  1. Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma

    Blood, Vol. 134, Núm. 5, pp. 421-431

2018

  1. Tailoring adjuvant endocrine therapy for premenopausal breast cancer

    New England Journal of Medicine, Vol. 379, Núm. 2, pp. 122-137

2017

  1. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

    The Lancet Oncology, Vol. 18, Núm. 11, pp. 1483-1492

2014

  1. Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

    New England Journal of Medicine, Vol. 371, Núm. 2, pp. 107-118

2011

  1. The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

    Annals of Oncology

2010

  1. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

    Blood, Vol. 116, Núm. 25, pp. 5650-5659

2009

  1. Real-Time 3-Dimensional Transesophageal Echocardiography in the Evaluation of Post-Operative Mitral Annuloplasty Ring and Prosthetic Valve Dehiscence

    Journal of the American College of Cardiology, Vol. 53, Núm. 17, pp. 1543-1547

2008

  1. The diagnosis and management of rectal cancer: Expert discussion and recommendations derived from the 9th world congress on gastrointestinal cancer, Barcelona, 2007

    Annals of Oncology